Letter

Do selective serotonin reuptake inhibitors cause suicide?: Risk of suicide should be assessed for whole class of antidepressants

BMJ 2005; 330 doi: 10.1136/bmj.330.7500.1148 (Published 12 May 2005)
Cite this as: BMJ 2005;330:1148.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. François Curtin, consultant (francoiscurtin@bluemail.ch),
  2. Pierre Schulz, head
  1. Clinical Psychopharmacology Unit, University of Geneva, 2 Ave du Petit-Bel-Air, CH-1225 Chene-Bourg/Geneva, Switzerland

    EDITOR—Gunnell et al's report on suicide risk with selective serotonin reuptake inhibitors (SSRIs) raises several issues.1

    Firstly, clinicians have observed that the first weeks of treatment of severe depression with an antidepressant are accompanied by a higher risk of suicide because of a drug induced motor disinhibition that is …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    Read related article

    See previous polls

    BMJ most popular